Business Context and Reporting Period
This Form 8-K Current Report was filed by Establishment Labs Holdings Inc. on June 1, 2022. The Company, incorporated in the British Virgin Islands, operates in the medical device sector, specifically manufacturing Motiva Implants. The report details a material definitive agreement entered into on June 1, 2022, effective May 13, 2022.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual agreement rather than financial performance results.
Material Changes
The Company entered into a new Master Supply Agreement with Nusil Technology LLC ("Nusil"), the sole supplier of medical-grade silicone for its Motiva Implants. This agreement supersedes and replaces the previous master supply agreement executed in 2016, which expired on May 13, 2022.
Outlook, Risks, and Unusual Items
- Agreement Terms: The new agreement establishes specified prices and general terms for the supply of medical-grade silicone.
- Duration: The initial term ends on December 31, 2026. It automatically renews for successive one-year terms for up to five years unless written notice is provided by either party no later than December 31 of the preceding year.
- Supply Chain Security: Securing a long-term agreement with the sole supplier of a critical raw material mitigates supply chain disruption risks for the Company's primary product line.
Investor Verification Checklist
- Review the full text of the Master Supply Agreement (Exhibit 10.1) to understand specific pricing mechanisms and redacted terms.
- Verify the Company's reliance on Nusil as the sole supplier for medical-grade silicone and assess potential concentration risk.
- Monitor future filings for any amendments to the agreement or changes in the supply chain status.